UPDATE 1-Express Scripts sees $750 mln in spending on new cholesterol drugs

Oct 6 (Reuters) - Express Scripts Holding Co, the largest manager of prescription drug plans for U.S. employers and health plans, said it has reached deals to cover two costly new cholesterol drugs and expects to spend no more than $750 million on them next year.